New psoriasis pill shows promise in Mid-Stage trial
NCT ID NCT06278350
First seen Jan 07, 2026 · Last updated May 23, 2026 · Updated 23 times
Summary
This study tested an experimental pill called D-2570 in 161 adults with moderate-to-severe plaque psoriasis. Participants took the pill or a placebo daily for 12 weeks. The main goal was to see if the pill could clear at least 75% of skin plaques. Results are being analyzed to determine if D-2570 is safe and effective enough to move to larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLAQUE PSORIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking University People's Hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.